The first author should be a member of JSCO to submit abstract, however this does not apply to the invited speakers, the overseas, the medical staff and students. Thus JSCO2022 also welcome abstracts from all those non-members.

※To become a member of the Japan Society of Clinical Oncology (JSCO)

If you wish to become a member of JSCO, please visit the JSCO website for further details.

All abstracts should be submitted through the online abstract submission system. We suggest you to have enough time for abstract submission since the line may be busy a few days before the submission deadline.

※About Abstract Submission System
 JSCO has introduced an abstract submission system for both general and invited speakers starting from JSCO 2014 Congress. This system enables JSCO members to obtain their registered membership data from "My Ganchi" system and reduce time to input personal information when registering abstracts.
 JSCO members are requested to check the registered membership data and update as necessary.

 1. JSCO Members and Applicants 

※If you have forgotten your Login ID and Password used for "my ganchi" system, please click here.

 2. JSCO Non-Members (Overseas, Medical Staff, Student)

※For security reasons, we are unable to answer any questions about your passwords.

 ■Invited Speakers

1. General Abstracts

• The presentation will be in the form of an oral or poster presentation, and it will be left to the Congress President and the Program Committee Members' discretion.

• Please make a PC-based presentation.

• In order to avoid gatherings during the poster panel presentations, all presentations will be e-poster presentation. All e-poster data should be submitted in advance. More details regarding e-poster presentations will be announced at a later date.

Industry-academic collaborative clinical oncology research entails benefits to society (public interest) from the fruits of discharging academic and ethical responsibility, as well as money, status, rights, and other benefits (private interest) acquired attendant on industry-academic collaboration. When these two types of benefit are in conflict within an individual researcher, it is called a “conflict of interest.” The occurrence of conflict of interest is unavoidable in today’s complex social activities, and legal restrictions apply to certain activities.

Click here for details >> Disclosure of COI

The Congress President and the Program Committee will select excellent abstracts from the submitted general abstracts. The best abstracts will then be chosen from those selected abstracts. The head authors of the best abstracts are requested to make an oral presentation at the Plenary Session either in English or Japanese.

• The Congress President and the Program Committee will select excellent abstracts by thoroughly reviewing the submitted general abstracts.
• The head authors whose abstracts have been selected as excellent abstracts are required to submit the abstract in English, in case the submitted abstracts are in Japanese.
• The excellent abstracts will be posted on the JSCO website.
  On the page for public: Authors' name, affiliation and abstract
  On the page for JSCO members: Authors' name, affiliation, abstract and presentation slides

The presentation style will be decided by the Congress President and the Program Committee Members. Please kindly note that we sometimes may not be able to meet your preference.

The notification of the abstracts result, presentation style, date and time will be sent to the first authors' registered email address from the Management Secretariat (jsco2022-ab@congre.co.jp) at late August.

The copyright of all accepted abstracts will be transferred to JSCO.
The abstracts submitted by the invited speakers will be posted on the JSCO website.

Click the button below to start your abstract submission.
Please note in advance that you will not be able to save the data in middle of the submission procedure.

c/o Congrès Inc.
1-9-17-11F Tenjin Chou-ku Fukuoka 810-0001, Japan
E-mail:jsco2022-ab@congre.co.jp